Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT06894836. HopeStage can help you review the study, but cannot decide medical eligibility.
Not Yet RecruitingNCT06894836
Hybrid Type 2 Implementation-Effectiveness study of a Third Wave Virtual Reality Treatment for Youth Depression/Anxiety
This study is not yet recruiting. It focuses on depression and currently lists study information in Global.
DepressionBehavioralFrom 12 Years to 25 Years
Key information made simple
This study is looking at how Third wave VR therapy works for people with Depression anxiety in routine care. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments. Taking part may give some people access to Third wave VR therapy with regular follow-up, but direct benefit is not guaranteed.
Your next step
The official record suggests a remote format run through a lab. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually meeting the main study requirements. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Orygen
- Sponsor type
- Unknown or unclear
- Main activity
- psychotherapy or therapy
- Intervention
- Not available
- Time commitment
- long follow-up or multiple visits
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Not Yet Recruiting
- Source
- Official registry link
Key study information
- Official title
- Hybrid Type 2 Implementation-Effectiveness Trial of a Third Wave Virtual Reality Treatment for Youth Depression/Anxiety
- Condition
- Depression Anxiety Disorder
- Study status
- Not Yet Recruiting
- Sponsor / lead affiliation
- Orygen
- Location / country
- Global
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT06894836
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help test a support approach in real life.
It requires regular follow-up, often through questionnaires or interviews.
Can be done remotely.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- Hybrid Type 2 Implementation-Effectiveness Trial of a Third Wave Virtual Reality Treatment for Youth Depression/Anxiety
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT06894836
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Hybrid Type 2 Implementation-Effectiveness study of a Third Wave Virtual Reality Treatment for Youth Depression/Anxiety?
This study is exploring psychotherapy or therapy for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Orygen. We could not clearly classify the sponsor type from the available data. Check the official source record to verify who is responsible for the study.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve psychotherapy or therapy, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me